Quintiles, Inc.

Clinical trials25

• Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)PHASE2 · COMPLETED · started Feb 26, 2018ClinicalTrials.gov NCT03487276 · fetched Nov 12, 2026
• AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology StudiesPHASE1 · COMPLETED · started Oct 27, 2017ClinicalTrials.gov NCT03313557 · fetched Nov 12, 2026
• Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)PHASE2 · COMPLETED · started Jul 27, 2017ClinicalTrials.gov NCT03029247 · fetched Nov 12, 2026
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active DiseasePHASE3 · COMPLETED · started Jan 25, 2017ClinicalTrials.gov NCT02760433 · fetched Nov 12, 2026
• A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle WeaknessPHASE2 · COMPLETED · started Dec 30, 2016ClinicalTrials.gov NCT02965573 · fetched Nov 12, 2026
• A Study of IMR-687 in Healthy Adult VolunteersPHASE1 · COMPLETED · started Oct 18, 2016ClinicalTrials.gov NCT02998450 · fetched Nov 12, 2026
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseasePHASE3 · COMPLETED · started Jun 6, 2016ClinicalTrials.gov NCT02760407 · fetched Nov 12, 2026
• MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy AdultsPHASE1 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02674347 · fetched Nov 12, 2026
• Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHDPHASE3 · COMPLETED · started Oct 28, 2015ClinicalTrials.gov NCT02652130 · fetched Nov 12, 2026
• A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)PHASE3 · COMPLETED · started Jun 4, 2015ClinicalTrials.gov NCT02336230 · fetched Nov 12, 2026
• Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back PainPHASE3 · COMPLETED · started Mar 6, 2015ClinicalTrials.gov NCT02412735 · fetched Nov 12, 2026
• Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung CancerPHASE2 · COMPLETED · started Jul 25, 2014ClinicalTrials.gov NCT02179671 · fetched Nov 12, 2026
• Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy SubjectsPHASE1 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02061358 · fetched Nov 12, 2026
• A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time MeasurementsNA · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02205827 · fetched Nov 12, 2026
• Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With EdoxabanPHASE2 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02207257 · fetched Nov 12, 2026
• A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT02025803 · fetched Nov 12, 2026
• A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)NA · COMPLETED · started Jul 1, 2012ClinicalTrials.gov NCT01664078 · fetched Nov 12, 2026
• Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung CancerPHASE1_PHASE2 · COMPLETED · started Jun 10, 2010ClinicalTrials.gov NCT01126736 · fetched Nov 12, 2026
• FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal CancerPHASE1_PHASE2 · TERMINATED · started Mar 4, 2010ClinicalTrials.gov NCT01133990 · fetched Nov 12, 2026
• First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-CisplatinPHASE3 · COMPLETED · started Nov 2, 2009ClinicalTrials.gov NCT00982111 · fetched Nov 12, 2026
• Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung CancerPHASE1_PHASE2 · COMPLETED · started Mar 1, 2009ClinicalTrials.gov NCT00894127 · fetched Nov 12, 2026
• Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 DiabetesPHASE3 · COMPLETED · started May 30, 2008ClinicalTrials.gov NCT00658021 · fetched Nov 12, 2026
• PRE-DETERMINE Cohort StudyACTIVE_NOT_RECRUITING · started Jul 1, 2007ClinicalTrials.gov NCT01114269 · fetched Nov 12, 2026
• A Safety and Efficacy Study in Patients With Gastric CancerPHASE3 · COMPLETED · started May 1, 2005ClinicalTrials.gov NCT00400179 · fetched Nov 12, 2026
• Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)PHASE3 · COMPLETED · started May 1, 1998ClinicalTrials.gov NCT00977483 · fetched Nov 12, 2026